GlassScriptPhysician profile
Tabitha Louise Beck
NPI 1184459307
$239.96
in general payments reported to CMS, 2019-2025
8 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $81.68 | 2025 | Pico 7, Allevyn Heel 10.5cm X 13.5cm Ctn 5, Collagenase Santyl |
| Convatec INC. | $31.98 | 2025 | |
| Organogenesis INC. | $29.43 | 2025 | Puraply Wound Matrix |
| Hollister Incorporated | $24.98 | 2025 | New Image, Adapt Ceraring |
| Coloplast Corp | $19.66 | 2025 | |
| Urgo Medical North America, LLC | $19.64 | 2025 | Urgoclean Ag |
| Mimedx Group, INC. | $16.55 | 2025 | |
| Kerecis Limited | $16.04 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tabitha Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.